Doctors Hospital 1997 LP

Doctors Hospital 1997 LP was paid $1.10M by Medicaid between Feb 2020 and Feb 2023, across 62 billing codes. Its largest line is 99284, emergency room visit (serious) — 55% of everything it billed.

33Billing provider infoDOCTORS HOSPITAL 1997 LP
HOUSTON, TX 77091

33aNPI1891741468assigned 05/25/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$1.10M

24GClaims23,365

24DCodes billed62

24AFirst – last monthFeb 2020 – Feb 2023

Compared with peers

Next to other General Acute Care Hospital providers in Texas

Rank by total paid#57 of 109

Median peer was paid$1.15M

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

OIG exclusionListed on the federal exclusion list (12/14/2023).

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	4,157	$161K
2021	10,167	$749K
2022	8,837	$182K
2023	204	$13K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	55%	2,019	1,939	$611K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	15%	3,680	3,009	$166K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	5.9%	4,217	3,053	$65K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.3%	548	520	$48K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	2.5%	3,460	2,854	$28K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.2%	125	108	$25K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	2.1%	122	119	$23K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.1%	28	26	$12K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	532	256	$11K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,259	1,219	$7K
80053	Comprehensive metabolic panel	<1%	1,052	1,025	$7K
0012A		<1%	305	305	$6K

50 more codes

0002A		<1%	250	$6K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	258	$5K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	125	$5K
87541		<1%	123	$5K
87640		<1%	125	$5K
87581		<1%	127	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	84	$5K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	253	$5K
87486		<1%	118	$5K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	157	$5K
69210		<1%	15	$5K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	125	$5K
0001A		<1%	316	$4K
99213	Doctor's office visit, returning patient (routine)	<1%	51	$4K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	315	$4K
80061	Lipid panel	<1%	346	$3K
84443	Thyroid stimulating hormone (TSH)	<1%	234	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	150	$3K
92567		<1%	17	$3K
88304		<1%	14	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	285	$2K
96361	Intravenous infusion, hydration; each additional hour	<1%	13	$2K
80074		<1%	97	$1K
Q3014	Telehealth originating site facility fee	<1%	534	$1K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	42	$1K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	356	$896.09
81003		<1%	376	$598.93
84550		<1%	206	$509.15
80048	Basic metabolic panel (calcium, ionized)	<1%	46	$466.05
A4663	Blood pressure cuff only	<1%	16	$359.46
82043		<1%	38	$336.00
82570		<1%	38	$300.95
0011A		<1%	88	$282.10
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	101	$174.45
84436		<1%	25	$172.59
84439		<1%	15	$160.30
81025		<1%	13	$160.15
80306		<1%	14	$85.02
84479		<1%	45	$82.00
92504		<1%	16	$23.30
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	16	$19.79
J7120	Ringers lactate infusion, up to 1000 cc	<1%	26	$6.50
0003A		0%	15	$0.00
84156		0%	14	$0.00
J7699	Noc drugs, inhalation solution administered through dme	0%	31	$0.00
J7030	Infusion, normal saline solution , 1000 cc	0%	13	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	279	$0.00
J2704	Injection, propofol, 10 mg	0%	31	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	13	$0.00
84480		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOEEN, FARIDA (CEO)